Crescent Biopharma, Inc. Financial Flexibility Index
Crescent Biopharma, Inc. financial flexibility index. Crescent Biopharma, Inc. (CBIO) has a Financial Flexibility Index of -1.00x as of June 2026. Free cash flow of $-19.45 Million (operating CF $-19.46 Million minus capex $13.00K) represents -1% of total liabilities ($19.50 Million). See how much free cash does Crescent Biopharma, Inc. generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Crescent Biopharma, Inc. (2011–2025)
Financial flexibility index of Crescent Biopharma, Inc. from 2011 to 2025. Historical Financial Flexibility Index trend for Crescent Biopharma, Inc. across 15 annual periods. Check Crescent Biopharma, Inc. earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Crescent Biopharma, Inc. Financial Flexibility Index by Year (2011–2025)
Crescent Biopharma, Inc. financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Crescent Biopharma, Inc.. For the full cash flow conversion analysis, see CBIO cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | $1.39 Million | $-71.53 Million | $37.28 Million | ▲ +106.1% |
| 2024 | -0.61x | $-31.09 Million | $-31.10 Million | $51.10 Million | ▲ +88.0% |
| 2023 | -5.05x | $-34.86 Million | $-34.88 Million | $6.90 Million | ▲ +3.3% |
| 2022 | -5.22x | $-46.37 Million | $-46.46 Million | $8.88 Million | ▼ -15.8% |
| 2021 | -4.51x | $-57.47 Million | $-57.49 Million | $12.74 Million | ▼ -68.2% |
| 2020 | -2.68x | $-39.17 Million | $-39.24 Million | $14.61 Million | ▲ +28.8% |
| 2019 | -3.76x | $-51.84 Million | $-51.98 Million | $13.77 Million | ▲ +18.3% |
| 2018 | -4.61x | $-43.21 Million | $-43.33 Million | $9.38 Million | ▼ -38.9% |
| 2017 | -3.32x | $-29.47 Million | $-29.77 Million | $8.88 Million | ▲ +19.0% |
| 2016 | -4.10x | $-29.03 Million | $-29.73 Million | $7.09 Million | ▼ -310.4% |
| 2015 | -1.00x | $-7.97 Million | $-8.24 Million | $7.99 Million | ▼ -58.4% |
| 2014 | -0.63x | $-4.07 Million | $-4.28 Million | $6.46 Million | ▲ +90.3% |
| 2013 | -6.51x | $-15.46 Million | $-15.54 Million | $2.38 Million | ▼ -277.3% |
| 2012 | -1.72x | $-10.16 Million | $-10.47 Million | $5.89 Million | ▼ -351.2% |
| 2011 | 0.69x | $14.04 Million | $13.85 Million | $20.45 Million | — |